Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide powder Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-tinted lyophilized powder Category: Research peptide reagent Intended Use This product is intended solely for: Laboratory experimentation Controlled in-vitro research Molecular and biochemical pathway studies Metal-peptide interaction research Non-human preclinical modeling Academic and institutional scientific projects Not intended for: Human or animal consumption Injection, ingestion, inhalation, topical, or cosmetic use Medical, therapeutic, or dermatological applications This material is not approved by Health Canada, FDA, or any regulatory body for clinical or cosmetic use
Growing E
Cytokine storm, in tandem with lymphopenia, lymphocyte dysfunction, and granulocyte/ monocyte abnormalities, could increase the disease severity of COVID-19 222
How It Is Studied In preclinical research, BPC-157 is typically administered via subcutaneous injection or oral gavage in rodent models, enabling researchers to compare systemic versus local delivery effects on target tissue endpoints
PMID 11934214
